MARIAMU TSHILENGE: Open Payments
NPI 1922739671 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 14 payments from 4 companies in 2025. Trend: 2023 $51 · 2024 $159 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 7 | $397 |
| ACADIA Pharmaceuticals Inc | 2 | $196 |
| Otsuka America Pharmaceutical, Inc. | 3 | $156 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
Products named: INGREZZA, NUPLAZID, REXULTI, AUSTEDO XR.
Industry payments across CT — which companies pay providers there.
